eXmoor Pharma

Bristol, United Kingdom

eXmoor Pharma is a technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.

$35.0M raised

May 2023

Series A

Biotechnology Life Science

Top Investors

MVM Life Science PartnersKineticos Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about eXmoor Pharma

How much funding has eXmoor Pharma raised?

eXmoor Pharma has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in May 2023.

Who are eXmoor Pharma's investors?

eXmoor Pharma's investors include MVM Life Science Partners, Kineticos Ventures.

Where is eXmoor Pharma headquartered?

eXmoor Pharma is headquartered in Bristol, United Kingdom.

What does eXmoor Pharma do?

eXmoor Pharma is a technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.

What stage is eXmoor Pharma at?

eXmoor Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 30, 2023.

MLA

"eXmoor Pharma — Funding & Investors." VCBacked, May 30, 2023, https://www.vcbacked.co/company/exmoor-pharma. Accessed June 17, 2026.

APA

VCBacked. (2023). eXmoor Pharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/exmoor-pharma

Wikipedia (cite web)

{{cite web |title=eXmoor Pharma — Funding & Investors |url=https://www.vcbacked.co/company/exmoor-pharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 30, 2023.

Similar Companies in Biotechnology